Form 8-K - Current report:
SEC Accession No. 0001193125-12-200840
Filing Date
2012-05-01
Accepted
2012-05-01 16:20:14
Documents
6
Period of Report
2012-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d342611d8k.htm 8-K 16150
2 CONSULTING AGREEMENT d342611dex101.htm EX-10.1 42771
3 PRESS RELEASE d342611dex991.htm EX-99.1 7800
4 GRAPHIC g342611ex10_1-pg001.jpg GRAPHIC 11122
5 GRAPHIC g342611ex99_1-pg001.jpg GRAPHIC 7076
6 GRAPHIC g342611ex99_1-pg002.jpg GRAPHIC 7076
  Complete submission text file 0001193125-12-200840.txt   103243
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 12800927
SIC: 2834 Pharmaceutical Preparations